18 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
clinical trials and upon any commercialization of any product candidates. Inadequate training in recognizing or managing the potential side effects … and to prevent security breaches, including costs related to deploying additional personnel and protection technologies, training employees, and engaging
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
degree from the University of Toronto in 1988. He completed specialty training in urologic surgery and oncology from 1993 to 1996, received a Master’s … in Public Health in epidemiology from Columbia University in 1997, and completed his oncology training at Memorial Sloan-Kettering Cancer Center. Dr
424B3
jqkgrl 2hik6
31 Mar 22
Prospectus supplement
11:42am
POS AM
8fmkql u0cc37i
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
3zxfha btegmt
5 Aug 21
Prospectus supplement
4:26pm
424B3
q1w2qwqpvgc6vq
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.18
y8v80ys7tn
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
iqc0 4jojpam
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.18
uxudwlursp o2fennrn8
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
4sul0psd
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
s7ds 8ntj8ft
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next